title: Risk of Myeloid Neoplasms in Inflammatory Bowel Disease Patients Is Linked to Exposure to Thiopurines and Not With Tumor Necrosis Factor-alpha Inhibitors.
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Parakkal
authors.initials: P
authors.lastname: Deepak
authors.affiliation: Research Institute, North Shore University Health System, Evanston, Illinois.
authors.forename: Derrick J
authors.initials: DJ
authors.lastname: Stobaugh
mesh_terms: D001379:Azathioprine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000453:epidemiology*
chemical_list: D007166:Immunosuppressive Agents; D001379:Azathioprine